The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Somatostatinoma Syndrome: Biochemical, Morphologic and Clinical Features
Abstract
Diabetes mellitus, steatorrhea, cholelithiasis and a tumor distorting the duodenum prompted a work-up for somatostatinoma in a 52-year-old man. The responses of pancreatic B-cells but not of A-cells to nutrient stimuli were inhibited, and growth-hormone release was suppressed, suggesting somatostatin resistance in some target tissues. Plasma somatostatin-like immunoreactivity ranged from 9000 to 13,000 pg per milliliter (normal: 88+/-8, mean +/- S.E.M.) and was distributed in four molecular forms, including free somatostatin. The primary tumor contained 5 microgram of somatostatin-like immunoreactivity per milligram of wet tissue, distributed in three of the molecular forms noted in plasma. Plasma calcitonin was also elevated (4650 pg per milliliter; normal: less than 120). Immunocytochemical studies showed that cells of the primary tumor contained somatostatin and calcitonin but no other peptide hormones. Only somatostatin was present in the metastases. Somatostatin was localized electron microscopically in all secretory granules, irrespective of size and shape, whereas calcitonin was present only within a single subpopulation of small granules in the same cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STUDIES ON ANTIBODY PRODUCTION
Coons, A. H., Leduc, E. H., & Connolly, J. M. (1955) · The Journal of Experimental Medicine · doi:10.1084/jem.102.1.49 · Cited by 1,555
Ultrastructural localization of intracellular antigens by the use of protein A-gold complex.
Roth, J., Bendayan, M., & Orci, L. (1978) · Journal of Histochemistry & Cytochemistry · doi:10.1177/26.12.366014 · Cited by 980
Self-citationStudies of pancreatic alpha cell function in normal and diabetic subjects
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106297 · Cited by 837
Self-citationLarsson, L.-I., Holst, J. J., Kühl, C., Lundqvist, G., Hirsch, M. A., Ingemansson, S., Lindkaer Jensen, S., Rehfeld, J. F., & Schwartz, T. W. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92113-4 · Cited by 318
“Somatostatinoma”: A Somatostatin-Containing Tumor of the Endocrine Pancreas
Ganda, O. P., Weir, G. C., Soeldner, J. S., Legg, M. A., Chick, W. L., Patel, Y. C., Ebeid, A. M., Gabbay, K. H., & Reichlin, S. (1977) · New England Journal of Medicine · doi:10.1056/nejm197704282961703 · Cited by 290
GERICH, J. E., LOVINGER, R., & GRODSKY, G. M. (1975) · Endocrinology · doi:10.1210/endo-96-3-749 · Cited by 164
Ipp, E., Dobbs, R. E., Arimura, A., Vale, W., Harris, V, & Unger, R. H. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108829 · Cited by 163
Self-citationSchally, A. V., Nair, R. M. G., Redding, T. W., & Arimura, A. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45877-8 · Cited by 160
Gastrointestinal somatostatin: extraction and radioimmunoassay in different species.
McIntosh, C. H. S., Arnold, R., Bothe, E., Becker, H. D., Köbberling, J., & Creutzfeldt, W. (1978) · Gut · doi:10.1136/gut.19.7.655 · Cited by 133
INHIBITION OF CHOLECYSTOKININ-PANCREOZYMIN RELEASE BY SOMATOSTATIN
Schlegel, W. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90182-9 · Cited by 99
The Characterization of Somatostatin-like Immunoreactivity in Human Serum
Kronheim, S. R., Berelowitz, M., & Pimstone, B. L. (1978) · Diabetes · doi:10.2337/diab.27.5.523 · Cited by 71
Kovács, K., Horváth, É., EZRIN, C., Sepp, H., & Elkan, I. O. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92578-8 · Cited by 60
Sakurai, H., DOBBS, R. E., & Unger, R. H. (1975) · Diabetologia · doi:10.1007/bf00429911 · Cited by 58
Self-citationThe Effect of Somatostatin on Release and Insulinotropic Action of Gastric Inhibitory Polypeptide
Pederson, R. A., Dryburgh, J. R., & Brown, J. C. (1975) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y75-168 · Cited by 56
Calcitonin Secretion by a Pancreatic Somatostatinoma
Galmiche, J. P., Colin, R., Dubois, P. M., Chayvialle, J. A., Descos, F., Paulin, C., & Geffroy, Y. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811302992213 · Cited by 51
Ion Transport Changes During Calcitonin-Induced Intestinal Secretion in Man
Gray, T. K., Brannan, P. G., Juan, D., Morawski, S. G., & Fordtran, J. S. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80442-8 · Cited by 48
Aydin, İ., Raskin, P., & Unger, R. H. (1977) · Diabetologia · doi:10.1007/bf01236318 · Cited by 35
Self-citationInhibitory effect of somatostatin on human pancreatic polypeptide secretion
Marco, J., Hedo, J., & Villanueva, M. L. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90406-4 · Cited by 32
Cited by
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
Pathophysiology of diabetes: An overview
Sameer, A., Banday, M., & Nissar, S. (2020) · Avicenna Journal of Medicine · doi:10.4103/ajm.ajm_53_20 · Cited by 756
Reichlin, S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312223092506 · Cited by 577
Molecular pharmacology of somatostatin receptor subtypes
Patel, Y. C. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03350317 · Cited by 409
Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms
Klöppel, G. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0013 · Cited by 336
Metadata
- Authors
- Krejs, G. J., Orci, L., Conlon, J. M., Ravazzola, M., Davis, G. R., Raskin, P., Collins, S. M., McCarthy, D. M., Baetens, D., Rubenstein, A., Aldor, T. A. M., & Unger, R. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1979-08-09
- Volume
- 301
- Issue
- 6
- Pages
- 285-292
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1989883614
- Cited by
- 395
- References
- 18
- FWCI
- 23.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.